928 related articles for article (PubMed ID: 32425074)
1. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
Basisty N; Kale A; Patel S; Campisi J; Schilling B
Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
[TBL] [Abstract][Full Text] [Related]
2. A proteomic atlas of senescence-associated secretomes for aging biomarker development.
Basisty N; Kale A; Jeon OH; Kuehnemann C; Payne T; Rao C; Holtz A; Shah S; Sharma V; Ferrucci L; Campisi J; Schilling B
PLoS Biol; 2020 Jan; 18(1):e3000599. PubMed ID: 31945054
[TBL] [Abstract][Full Text] [Related]
3. Isolation methodology is essential to the evaluation of the extracellular vesicle component of the senescence-associated secretory phenotype.
Wallis R; Josipovic N; Mizen H; Robles-Tenorio A; Tyler EJ; Papantonis A; Bishop CL
J Extracell Vesicles; 2021 Feb; 10(4):e12041. PubMed ID: 33659050
[TBL] [Abstract][Full Text] [Related]
4. Translating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies.
Dey AK; Banarjee R; Boroumand M; Rutherford DV; Strassheim Q; Nyunt T; Olinger B; Basisty N
Biology (Basel); 2023 Oct; 12(10):. PubMed ID: 37887011
[TBL] [Abstract][Full Text] [Related]
5. Senescence and the SASP: many therapeutic avenues.
Birch J; Gil J
Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
[TBL] [Abstract][Full Text] [Related]
6. Senopathies-Diseases Associated with Cellular Senescence.
Lushchak O; Schosserer M; Grillari J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
[TBL] [Abstract][Full Text] [Related]
7. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence in bone.
Farr JN; Khosla S
Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
[TBL] [Abstract][Full Text] [Related]
9. Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype.
Jakhar R; Crasta K
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137607
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.
Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
Mol Aspects Med; 2018 Apr; 60():92-103. PubMed ID: 29146100
[TBL] [Abstract][Full Text] [Related]
11. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
12.
Samakkarnthai P; Saul D; Zhang L; Aversa Z; Doolittle ML; Sfeir JG; Kaur J; Atkinson EJ; Edwards JR; Russell GG; Pignolo RJ; Kirkland JL; Tchkonia T; Niedernhofer LJ; Monroe DG; Lebrasseur NK; Farr JN; Robbins PD; Khosla S
Aging (Albany NY); 2023 May; 15(9):3331-3355. PubMed ID: 37154858
[TBL] [Abstract][Full Text] [Related]
13. Cellular Senescence: A Translational Perspective.
Kirkland JL; Tchkonia T
EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
[TBL] [Abstract][Full Text] [Related]
14. The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases.
Cuollo L; Antonangeli F; Santoni A; Soriani A
Biology (Basel); 2020 Dec; 9(12):. PubMed ID: 33371508
[TBL] [Abstract][Full Text] [Related]
15. Senescent Cells in Cancer: Wanted or Unwanted Citizens.
Niklander SE; Lambert DW; Hunter KD
Cells; 2021 Nov; 10(12):. PubMed ID: 34943822
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Proteomic Analysis of the Senescence-Associated Secretory Phenotype by Data-Independent Acquisition.
Neri F; Basisty N; Desprez PY; Campisi J; Schilling B
Curr Protoc; 2021 Feb; 1(2):e32. PubMed ID: 33524224
[TBL] [Abstract][Full Text] [Related]
17. Senescent cells and SASP in cancer microenvironment: New approaches in cancer therapy.
Özdemir A; Şimay Demir YD; Yeşilyurt ZE; Ark M
Adv Protein Chem Struct Biol; 2023; 133():115-158. PubMed ID: 36707199
[TBL] [Abstract][Full Text] [Related]
18. The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets.
Rossi M; Abdelmohsen K
Cells; 2021 Jul; 10(7):. PubMed ID: 34359910
[TBL] [Abstract][Full Text] [Related]
19. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
20. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]